Evommune (EVMN) Interest Coverage Ratio (2024 - 2026)

Evommune's (EVMN) quarterly Interest Coverage Ratio came in at 0.26 in Q1 2026, up 99.65% year-on-year from 0.13 in Q1 2025, and down 100.34% on a QoQ basis from 75.61 in Q4 2025.

Evommune (EVMN) Interest Coverage Ratio (2024 - 2026) Analysis & Trends

Evommune (EVMN) has 3 years of Interest Coverage Ratio data on file, last reported at 0.26 in Q1 2026.

  • On a quarterly basis, Interest Coverage Ratio rose 99.65% year-over-year to 0.26 in Q1 2026; TTM through Mar 2026 was 0.89, a N/A change from a year earlier, with the FY2025 full-year figure at 1.49, up 98.3% from the prior year.
  • Interest Coverage Ratio for Q1 2026 stood at 0.26, down from 75.61 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for EVMN reached as high as 75.61 in Q4 2025 and fell as low as 971.59 in Q3 2024.
  • Historically, Interest Coverage Ratio has averaged 155.87 across 3 years, with a median of 1.09 in 2025.
  • On a YoY basis, Interest Coverage Ratio climbed as much as 99.8% in 2025 and fell as far as 98.43% in 2025.
  • Year by year, Interest Coverage Ratio stood at 38.11 in 2024, then soared by 98.43% to 75.61 in 2025, then plunged by 100.34% to 0.26 in 2026.
  • Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.26 in Q1 2026, 75.61 in Q4 2025, and 1.93 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Evommune 381.48 Mn 170.02 Mn - -0.26

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.26
Dec 31, 2025 75.61
Sep 30, 2025 -1.93
Mar 31, 2025 -75.16
Dec 31, 2024 38.11
Sep 30, 2024 -971.59